An important mechanism explaining the melatonin-mediated inhibition of tumor growth is related to the inhibition of the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) and EGFR signaling pathways in various cancer cell lines [36]. The gene discussed is AKT1; the disease is neoplasm.